• Financial Report: Lilly contractpharma
    April 24, 2020
    Revenue up 15% in the quarter due to key growth products Trulicity, Taltz, Verzenio, Emgality, Basaglar, Jardiance, and Baqsimi.
PharmaSources Customer Service